The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 382
- Registration Number
- NCT03288038
- Locations
- 🇰🇷
Kangbuk Samsung Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Anam Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
Cohort Event Monitoring Study of Pyramax®
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 8572
- Registration Number
- NCT03201770
- Locations
- 🇬🇦
CERMEL, Albert Schweitzer Hospital, Lambaréné, Gabon
🇨🇲The Biotechnology Center Nkolbisson, Univ of Yaounde I, Messa, Yaoundé, Cameroon
🇨🇮Institut Pierre Richet / Institut National de SanPublique (IPR/INSP), Bouaké, Côte D'Ivoire
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 392
- Registration Number
- NCT02944734
- Locations
- 🇰🇷
Kyungpook National University Hospital, Joong-gu, Daegu, Korea, Republic of
🇰🇷Catholic University of Korea Bucheon St. Mary's Hospital, Wonmi-gu, Bucheon, Korea, Republic of
🇰🇷Inje University Busan Paik Hospital, Busanjin-gu, Busan, Korea, Republic of
Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
- Conditions
- Ischemic Stroke
- Interventions
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02787278
- Locations
- 🇰🇷
Pusan National University Hospital, Busan, Korea, Republic of
🇰🇷Asan Medical Center, University of Ulsan, Seoul, Korea, Republic of
🇰🇷Kyungpook National University Hospital, Daegu, Korea, Republic of
Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg
- First Posted Date
- 2013-08-21
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT01926652
- Locations
- 🇰🇷
Chungnam national university hospital, clinical trial center, Daejeon, Chungcheongbul-do, Korea, Republic of
Safety, Tolerability and Pharmacokinetics of SP-8203
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT01757795
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of